Stock Market

In early August, I wrote about how shares of T2 Biosciences (NASDAQ:TTOO) could rise to $1 or more in a short-term frenzy. Meme investors had singled out the stock, and heavy options trading meant shares were at risk of getting squeezed. Retail investors delivered. Within two weeks, TTOO’s stock had risen from 30 cents to

Microsoft (NASDAQ:MSFT) is a member of the “Magnificent Seven” group of tech firms. However, don’t assume that MSFT stock will deliver magnificent returns like it did in 2023’s first half. Sure, Microsoft’s investors will get exposure to the artificial intelligence market. Yet, current and prospective shareholders should be aware of a significant competitor that Microsoft will

Plenty have thrown in the towel with positions in Lucid Group (NASDAQ:LCID), but many analysts and investors remain optimistic about the future prospects of LCID stock. While others have headed for the exits, they’ve held on, continuing to argue the consistently-questionable bull case for the struggling electric vehicle maker’s shares. In fact, just recently, the

“Social media is the ultimate equalizer. It gives a voice and a platform to anyone willing to engage.” –Amy Jo Martin This has not been a healthy market by any means. As I’ve noted numerous times, the vast majority of stocks have performed sub-par in what is otherwise supposed to be a strong year given

Towards the end of 2021, Nvidia (NASDAQ:NVDA) stock was trading at $300. NVDA stock corrected to lows of $108 by October 2022 before skyrocketing by more than 200% for year-to-date. The point I want to make is that the rally in blue-chip stock can be stellar from oversold levels. It does not take time for

Lucid Group (NASDAQ:LCID) stock is one I’ve had mixed opinions of in the past. On the one hand, this is a company with some clear speculative upside, particularly as a vehicle for investors to bet on the overall electric vehicle space. However, it’s also clear that Lucid Group is one that has been plagued by

Meta Platforms (NASDAQ:META) stock has surged 150% in 2023. But most of the gain isn’t based on reality. Instead, Meta has gone from being one of the most-hated stocks on Wall Street to one of the most loved, thanks to artificial intelligence. At the start of 2023, Meta stock was bouncing around the 120s. It

Certain stocks have surged this year, with hyper-growth tech companies seeing some of the biggest gains. The three companies listed below have highlighted what momentum can mean for sustained moves higher, even though these stocks are all down at least 10% from their all-time highs, at the time of writing.  Many investors question whether this

Recent industry and macro factors caused Nvidia (NASDAQ:NVDA) stock to dip, sparking concerns about its 2023 rally. Despite a slight decline, don’t dismiss the ongoing generative AI mega trend driving its powerful performance.  That said, investors should recognize the limits of Nvidia’s growth potential despite the market’s enthusiasm for AI. While NVDA benefits from AI

SoFi Technologies (NASDAQ:SOFI) is a banking sector disruptor that’s garnered a lot of attention on Wall Street. Opinions vary, but one notable theme among analysts is that SOFI stock looks overvalued. I tend to agree, and while I like SoFi Technologies as a company, I recommend that prospective investors wait for the share price to come

As the EV landscape shifts, investors considering Lucid Group (NASDAQ:LCID) stock for its recent strong performance have been rewarded. Momentum has taken LCID stock on a bumpy, but upward ride this year. And while Lucid has seen its valuation come down from its peak in Q1, there are reasons some investors remain very bullish on

Shares of Massachusetts-based T2 Biosystems (NASDAQ:TTOO) surged another 30% this week on meme stock interest. According to financial data provider Fintel.io, retail ownership has now risen over six-fold since last month. In a sense, T2’s rapid ascent comes as no surprise. Shares of the highly shorted healthcare firm have risen 110% since the start of

Bloom Energy (NYSE:BE) stock is puzzling. Th company continues to grow its hydrogen fuel cell business but it has yet to see a profit. The second quarter report is typical. Bloom announced on Aug. 3 that second quarter sales were up nearly 24%, compared to the same quarter a year ago. But there was still

In 2014, Massachusetts-based T2 Biosystems (NASDAQ:TTOO) went public at $11 per share. Expectations were high for the young startup. Its sepsis-detecting products targeted a $20.3 billion industry, and T2’s Magnetic Resonance Platform (T2MR) was potentially game-changing. Shares would quickly rise to a pre-split $23. The product, however, would prove a dud. In 2020, most of

While Upstart (NASDAQ:UPST) focuses on artificial intelligence in 2023, the company isn’t just jumping on the AI bandwagon. UPST stock earns a solid “B” grade because Upstart is deploying its technology in a useful and interesting way. Financial traders should weigh their tolerance for risk before considering an investment in Upstart. What Upstart seeks to achieve

The biotech industry proved itself resilient in the face of the COVID-19 pandemic. With research from Mckinsey, venture capitalist (VC) companies increased investments from 2,200 in 2016 to 3,100 in 2021 in biotechnology (biotech) startups. These startups have advanced medicine overall, improving cell therapy, tissue regeneration, genetic medicine, and more. With increasing innovation, we see

It’s worth noting that blue-chip stocks go through their own bull and bear phase. Nvidia (NASDAQ:NVDA) was under-performing until October 2022. The massive rally in the last three quarters has more than compensated for the bear phase. With strong fundamentals, several other undervalued blue-chip stocks are worth considering for the long-term even as the markets

Last week, meme investors “discovered” Rite Aid (NYSE:RAD), sending its shares up 70%. The Wall Street Journal would quickly give the company a meme stock crown. For most traditional investors, Rite Aid looks like a terrible bet. The struggling drug retailer hasn’t been profitable since 2017, and a deal five years ago to sell 1,932